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Umbilical cord blood transplants are now used to treat numerous types of immune- and blood-related dis-
orders and genetic diseases. Cord blood (CB) banks play an important role in these transplants by processing
and storing CB units. In addition to their therapeutic potential, these banks raise ethical and regulatory
questions, especially in emerging markets in the Arab world. In this article, the authors review CB banking in
ﬁve countries in the region, Jordan, Saudi Arabia, Egypt, Qatar, and the United Arab Emirates, selected for their
different CB banking policies and initiatives. In assessing these case studies, the authors present regional
trends and issues, including religious perspectives, policies, and demographic risk factors. This research
suggests strong incentives for increasing the number of CB units that are collected from and available to Arab
populations. In addition, the deﬁcit in knowledge concerning public opinion and awareness in the region
should be addressed to ensure educated decision-making.
 2015 American Society for Blood and Marrow Transplantation.INTRODUCTION
In 1988, the ﬁrst stem cell transplant using umbilical cord
blood (CB) was performed to treat a pediatric patient
suffering from Fanconi’s anemia. Ten years later, the ﬁrst CB
transplant was carried out in the Arab world, and as the
number of transplants continues to increase, the infrastruc-
ture for CB collection and storage has expanded [1]. The
establishment of CB banks has expanded rapidly over the
past decade, fueled largely by promising advances in CB
transplantations.
The Arab world in particular is witnessing a proliferation
in CB banks, often preceding regulatory policies and public
discussions. Despite varying economic and political priorities
in the region, several unique factors, including fertility rate
and disease incidence, relate especially to CB banking
(Table 1). Most controversial are the for-proﬁt CB banks that
have found an enthusiasticdbut arguably under-infor-
meddclientele in Arab countries. In addition, research onedgments on page 1193.
equests: Kirstin R. W. Matthews, PhD,
Policy, 6100 Main Street, Baker Hall MS-
(K.R.W. Matthews).
15.01.012
ty for Blood and Marrow Transplantation.public opinion is needed to help create strong national and
regional policy frameworks for CB banking programs.BANKING MODELS: PUBLIC, PRIVATE, AND HYBRID
The discovery that CB contains hematopoietic stem cells
(HSCs) turned the umbilical cord from disposable waste into a
valuable resource. CB transplants have become standard ther-
apies for numerous indications, and hundreds of clinical trials
are being carried out internationally to investigate CB’s thera-
peutic potential for a wider range of disorders, including
autism, diabetes, and cerebral palsy. More than 3 million CB
units are in storage around the world, with about 650,000 in
public banks and 2.5 million in private facilities [2].
CB is collected after childbirth without adversely affecting
the mother or infant. After collection, the bank tests the unit
for diseases and viability for transplant and then freezes the
eligible units until needed for transplant or, in some cases,
research. CB is used for both allogeneic (related and unre-
lated) and autologous transplants. CB can be donated to a
public bank where it can be accessed by any patient in need
of a transplant. Conversely, parents can pay to store the CB
unit in a private bank for family use. Hybrid banks have
varying combinations of both public and private storage.
In the Arab world, only a few public CB banks exist
(Table 2). Public banks collect and process donated CB
Table 1
Relevant Demographic, Health, and Economic Indicators of 5 Arab Countries Studied: Jordan, Saudi Arabia, UAE, Egypt, and Qatar
Country Population Arab Fert GNI Health $ Hosp Beds Leukemia Lymphoma
Jordan 7.93M 98% 3.16 $4.95k 8.4% 1.8 6.1 8.2
Saudi Arabia 27.3M 90% 2.17 $26.2k 3.7% 2.2 3.8 7.9
UAE 5.63M 13%k 2.36 $38.6k 3.3% 1.9 3.7 6.7
Egypt 86.9M 99% 2.87 $3.16k 4.9% 1.7 5.9 9.3
Qatar 2.12M 40% 1.92 $85.5k 1.9% 1.2 4.9 7.7
These countries were chosen for their unique policy and CB banking initiatives and programs as well as relevant demographic factors. Information is included on
demographics: population in millions, percent of population of Arab ethnicity (Arab), and total fertility rate (Fert)*; economics: gross national income per capita
(GNI)y and percent of gross domestic product for health expenditures (Health $); and health: hospital bed densityz (Hosp beds) and age-standardized incidence
ratesx of leukemia and lymphoma (both Hodgkin and non-Hodgkin).
* Total fertility rate is a better measure of fertility level than crude birth rate and is the average number of children that would be born per woman if all women
lived to the end of their childbearing years and bore children according to a given fertility rate at each age.
y GNI is the sum of value added by all resident producers plus any product taxes (less subsidies) not included in the valuation of output plus net receipts of
primary income (compensation of employees and property income) from abroad. Per capita rates are determined by dividing GNI by the midyear population.
GNI per capita indicates the average national income, converted to US dollars using theWorld Bank Atlas method to smooth ﬂuctuations in prices and exchange
rates.
z Hospital bed density is the number of hospital beds per 1000 people, serving as a general indicator of inpatient service availability.
x Age-standardized rate is the number of new cases or deaths per 100,000 persons per year; it is the rate a population would have if it had a standard age
structure.
k Current demographic data on the UAE population is out of date and incomplete; however, its National Bureau of Statistics estimates about 13% of the
population to be Emirati nationals. Sources: Central Intelligence Agency. World Factbook 2014. Available at: https://www.cia.gov/library/publications/the-
world-factbook/index.html. Accessed October 30, 2014; United Arab Emirates National Bureau of Statistics. Population by Nationality. Available at: http://
www.uaestatistics.gov.ae/ReportPDF/Population%20Estimates%202006%20-%202010.pdf. Accessed November 1, 2014; WHO International Agency for Research
on Cancer. GLOBOCAN 2012: Estimated cancer incidence mortality and prevalence worldwide. Available at: http://globocan.iarc.fr/Pages/fact_
sheets_population.aspx. Accessed October 30, 2014; The World Bank. Table 1.1 World development indicators: size of the economy. Available at: http://
wdi.worldbank.org/table/1.1. Accessed November 11, 2014.
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transplant center for the ﬁrst patient in need. Public banks
are not ﬁnancially self-sustainable and are primarily funded
by the government, charitable sources, and revenue from
exporting CB units to transplant centers. Although there are
no mandatory international regulations on public CB banks,
to register CB units on a database accessible by transplant
centers, the bank usually has to meet certain accreditations
or standards. For example, the Foundation for the Accredi-
tation of Cellular Therapy (FACT) accredits CB banks using the
NetCord-FACT quality standards, which are universally
recognized by transplant centers around the world.
Currently, only 2 banks in the Arab worldd1 in Riyadh and 1
in Dubaidhave met the NetCord-FACT requirements to
participate in NetCord’s international online database of CB
units (Table 2). Governments may have alternative or addi-
tional national policies to regulate CB banks.
Several public CB banks have begun offering a “family-
directed” donation program that allows families with either a
current transplant need or a history of diseases treatable
with CB to donate the unit at minimal-to-no cost to the
family member in need [3]. This type of storage requires
prescreening and counseling to inform families about op-
tions. However, it is generally considered a ﬁnancially,
medically, and ethically sound option.
Private CB banks have attracted many clients among Arab
populationsdtheir services currently outnumber public
banking options (Table 2). However, most private banks are
US- or UK-based and store the CB units in facilities outside of
the Arab world. Private banks advertise their services to the
general public and charge clients for CB collection, process-
ing, and storage, which total about $4000 per unit for 20
years of storage. With a low average income in many Arab
countriesd$4950 in Jordan and $3160 in Egyptdthese costs
are prohibitive to the majority of the populations (Table 1)
[4].
Private CB banks depend on revenue from clients and
therefore may be driven by economic competition to use
ethically questionable recruitment tactics. Populations thatare unaware of other CB banking options may be especially
vulnerable to these advertisements. For example, company
representatives may approach parents at emotionally
vulnerable times (eg, during labor), present biased infor-
mation about CB storage as “biological insurance” for the
newborn, and give a false impression about the likelihood of
needing a CB transplant. Data about autologous CB trans-
plants are limited, but research has estimated the likelihood
of needing one during the ﬁrst 20 years of life (ie, when the
frozen unit is still viable) to be very unlikely, ranging from
1:2500 (or .04%) to 1:200,000 (or .0005%), depending on
inclusion criteria [5]. In addition, the quality of the CB unit
may be inadequate for transplant because regulations for
private banks are often less stringent and many private CB
banks store the collected CB unit regardless of its viability.
A newer type of CB bank is the hybrid model, which offers
a combination of public and private CB storage. Some hybrid
banks store a portion of the CB unit publicly and another
portion privately, whereas others give parents the choice to
either donate the CB for public storage or keep it privately. In
either case, hybrid banks can use the revenue from private
storage to offset the costs of the public side and can have the
added advantage of providing parents with a choice.
CASE STUDIES FROM THE ARAB WORLD
Five countries in the Arab worlddJordan, Saudi Arabia,
Qatar, Egypt, and the United Arab Emirates (UAE)dstand out
for their unique CB banking policies or new program initia-
tives and investments (Tables 1 and 3). Although private CB
banks dominate in the region, several public banks are
already in operation, and additional plans are in progress.
Jordan
Jordan is a regional standout in medical infrastructure
and scientiﬁc research. It currently spends the highest per-
centage of its gross domestic project on health among all
Arab countries. The King Hussein Cancer Center (KHCC),
operated by the Ministry of Health, is at the helm of HSC
transplant activity. In addition, Jordan recently passed a
Table 2
Current CB Banking Options in the Arab World
CB Bank Type Storage Location Collection Ofﬁce Location(s)
BabyCord Priv USA (Boston), Jordan (Amman)* Jordan
Biovault Family Priv UK (Plymouth) Lebanon, UAE
CellSafe Priv Egypt (Cairo) Egypt
Cells4Life Priv UK (Burgess Hill, Essex) Bahrain, Egypt, Jordan, Kuwait, Lebanon, Qatar,
Saudi Arabia, UAE
Center for Stem Cell
Research & Regenerative Medicine
Publ Egypt (Assiut)* Egypt
Cryo-Save Priv UAE (Dubai), Belgium (Niel) Egypt, Kuwait, Oman, Saudi Arabia, UAE
DCRCy Hybr UAE (Dubai) UAE
Future Health Biobank Priv UK (Nottingham), Switzerland
(Châtel-St-Denis)
Bahrain, Egypt, Jordan, Kuwait, Lebanon, Morocco, Qatar,
Saudi Arabia, Syria, UAE
KAIMRC Publ Saudi Arabia (Riyadh) Saudi Arabia
KFSH-RCy Publ Saudi Arabia (Riyadh) Saudi Arabia
KHCC Publ Jordan (Amman)* Jordan
Precious Cells Priv UK (Middlesex) Jordan, Lebanon, UAE
Smart Cells Priv UK (West Drayton) Egypt, Jordan, Kuwait, Lebanon, Syria, UAE
Sultan Qaboos Univ. Hospital Publ Oman (Muscat) Oman
Virgin Health Bank Priv, Hybr Qatar (Doha) Qatar
Three types of bank (Type) collect cord blood in the region. Themajority are private facilities (Priv) that store the units outside of the region. Several public banks
(Publ), as well as 2 hybrids (Hybr), have opened. Two banks are NetCord members (y).
* Indicates the CB bank storage facility is currently under construction.
y Indicates CB banks that are Provisional Members of the NetCord consortium. These banksmust complywith NetCord-FACT quality standards and have access
to NetCord’s online registry, so patients across the world can access their CB inventory.
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the region.
KHCC was founded in 1997 and began its HSC transplant
program in 2003. It performs approximately 100 HSC
transplants from bone marrow each year and is currently the
only program in Jordan that carries out CB transplants, pro-
curing units from international sources [6,7]. CB transplants
have shown to help bypass long waiting times, which can
reach 3 years for thalassemia patients in Jordan [8].
KHCC is currently building a stem cell unit that includes
CB storage space. This new facility will include the ﬁrst public
CB bank in Jordan, which will be funded through revenue
generated by the KHCC transplant center and additional
support from the KHCC Foundation. KHCC may later adopt a
hybrid model by opening a section for private storage toTable 3
Timeline of Major CB Banking Developments in the Arab World
Year Development
1998 First CB transplant is performed in Arab
2003 SA: KFSH-RC begins performing CB trans
Muslim World League’s Jurisprudential C
2006 UAE: DCRC opens ﬁrst CB bank in the reg
SA: KFSH-RC opens the Kingdom’s ﬁrst p
UAE: Cryo-Save Arabia, the largest privat
2007 EG: National Blood Policy is approved w
2009 QA: Virgin Health Bank moves its headqu
EG: CellSafe opens as the country’s ﬁrst p
2011 QA: Virgin Health Bank is granted the ﬁr
SA: KAIMRC opens the country’s second
QA: Virgin Health Bank opens storage an
EG: National Stem Cell Committee is crea
and therapy as well as a public CB bank
2012 EG: Stem cell research center opens at Sh
QA: Stem cell research policy is enacted
2013 EG: Center for Stem Cell Research and Re
2014 JO: New stem cell research law is passed
2015 JO: Projected opening of the ﬁrst in-coun
EG: Projected opening of the country’s ﬁ
Zewail City of Science & Technology
2016 JO: Projected opening of the country’s ﬁr
Over the past decade, several Arab countries have had signiﬁcant activities related
recently, new developments have been centered in Egypt (EG), Qatar (QA), and Joincrease funding sources. In anticipation of the growth of the
HSC transplant program and the demand for CB units, KHCC
is planning to establish a national CB registry database so
that patients can locate donors [9].
Several private companies offer CB collection and storage
services in Jordan. However, with an average income of less
than $5000, the high costs are only accessible for the
economically elite. For example, BabyCord Jordan, a US-
based private CB bank, charges over $2000 for the initial
collection and ﬁrst year of storage and an additional $200
each year thereafter. The company recently built a storage
facility in Jordan and applied for a license to expand its ser-
vice, making it the ﬁrst private CB facility in the country.
In January 2014, after several years of meetings and draft
laws, the Jordanian government passed new stem cellworld
plants (from imported units)
ouncil issues a fatwa approving CB for research and therapy
ion, as a publiceprivate hybrid model
ublic CB bank
e CB storage facility in the region, opens in Dubai Healthcare City
ith procedural guidelines for CB collection and storage
arters from London to Doha
rivate CB bank
st (and only, to date) license for CB procurement, processing, and storage
public CB bank and creates the Saudi Donor Registry
d processing facility at Qatar Science & Technology Park
ted and tasked with establishing regulations for stem cell research
eikh Zayed Hospital
into legislation, allowing research using CB stem cells
generative Medicine opens in Zewail City of Science & Technology
, including regulations for CB banking
try private CB storage facility by the company, BabyCord Jordan
rst public CB bank, located at Assiut University, in partnership with
st public CB bank, located at KHCC
to CB banking, starting primarily with Saudi Arabia (SA) and the UAE. More
rdan (JO).
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the Ministry of Education, the National Committee for Sci-
ence and Technology Ethics, and Jordan’s Religious Council
(Majlis Al-Iftaa) [10]. The law is the ﬁrst in the Arab world to
include CB banks and is permissive toward adult stem cells,
including those derived from CB, and puts strict regulations
on private banks by requiring licensure and regular moni-
toring of facilities and procedures. In addition, the law
mandates a national committee composed of members from
relevant ﬁelds who are tasked with evaluating a company’s
legal compliance at each stage of the license granting pro-
cedure. The national committeewill also update the stem cell
regulations in concordance with new advances in the ﬁeld of
stem cell research and therapy, making the law not only
dynamic but also open minded and conducive toward sci-
entiﬁc research.
Saudi Arabia
The Saudi bioethics committee, established in 2002 by
royal decree, permits research using stem cells, including
those procured from CB [11]. Policies related to CB and CB
banking are based on the 2003 fatwa (Islamic legal ruling)
issued by the Muslim World League’s Islamic Jurisprudential
Council. The ruling permits the use of stem cells from “the
placenta or umbilical cord with the permission of the par-
ents” for research and therapy [12]. The Saudi Ministry of
Health also formed a national committee tasked with over-
seeing CB banks, creating licensing procedures, and estab-
lishing regulations [13]. In early 2011, the Ministry of Health
closed several ofﬁces in the Kingdom that were allegedly
coordinating with foreign private banks and advertising
treatment options using prohibited, unlicensed approaches
[14].
In 2003, the King Faisal Specialist Hospital and Research
Center (KFSH-RC) began performing transplants using CB
units imported from international registries. A public bank
was created in 2006 at KFSH-RC, which now stores over 4600
units. As of 2013, it had transplanted 121 locally stored units
to 108 patients (103 children, 5 adults) [15,16]. In 2010, over
10% (25 of 119) of its allogeneic HSC transplants were per-
formed using CB and 88% (22 of the 25) of the CB units were
procured locally [17]. The number of local CB units trans-
planted annually increased from 1 to 30 between 2008 and
2011, with a concomitant decrease in the number of inter-
national units used, from 29 to 3 [15]. KFSH-RC was ofﬁcially
recognized as a FACT-accredited organization in 2012,
joining the NetCord consortium as a provisional member and
becoming 1 of 2 member banks in the Arab world.
KFSH-RC’s bank is extending its collection and storage
capabilities, with plans to cooperate with local hospitals to
collect CB units from different regions in Saudi Arabia and to
build a new facility at King Abdullah Center for Kidney Dis-
eases. CB units from Saudi donors have demonstrated a high
degree of matching for allogeneic transplants in Saudi pa-
tients [18]. The bank claims to have achieved 90% coverage of
all Saudis who do not have a matching family donor [16].
Transplanting locally stored CB units is signiﬁcantly cheaper
than using international unitsd$8000 versus $40,000,
respectively.
A second CB bank opened at King Abdullah International
Medical Research Center (KAIMRC) in 2011, operated by the
National Guard Health Affairsdthe Kingdom’s major body
that oversees its medical complexes [19]. This bank accepts
CB donations for either allogeneic transplant or research. It
now stores approximately 2000 CB units, and the HSCtransplantation program has carried out close to 200 trans-
plants over the past 3 years [20]. Notably, the National Guard
Health Affairs established the ﬁrst stem cell donor registry in
the region in an effort to increasematching rates among Arab
citizenry and now lists over 5000 donors [21].
United Arab Emirates
The Dubai Cord Blood and Research Center (DCRC), which
opened in June 2006, was the ﬁrst CB bank in the Arab world
[22]. As a hybrid bank, it is currently the only facility in the
UAE to offer public storage. CB collection occurs at desig-
nated hospitals run by the Dubai Health Authority, although
transportable collection kits are now being used for child-
births outside of these centers [23]. Like the Saudi bank at
KFSH-RC, DCRC’s CB bank is a provisional member of the
NetCord consortium, with a set goal of becoming a full
member in the future.
DCRC increased its number of registered CB units be-
tween 2011 and 2012 by nearly 50%. This surge stems from
education and awareness campaigns it implemented after
survey results revealed parents were lacking information
about CB banking. As of 2013, the facility had stored over
3300 units (less than 20% of which are in public storage) and
had transplanted 9 units, all of them in children [22]. DCRC
subsidizes the cost of private banking at approximately
$2500 for collection and 25 years of storage.
Several private CB banks provide collection and banking
services to the UAE. All of them are more expensive than
DCRC’s private storage option, and all but 1 store the CB units
abroad. Cryo-Save Arabia opened in 2006 and is the largest
private CB facility in the Arab world. The bank stores units in
Dubai Biotechnology and Research Park (DuBiotech) that
have been collected from countries throughout the region,
including Bahrain, Egypt, Kuwait, Lebanon, Oman, Qatar, and
Saudi Arabia. It has received accreditation from the US Food
and Drug Administration as well as a clinical operating li-
cense from the Center for Healthcare Planning and Quality,
the independent regulatory body that sets standards for
companies that operate at Dubai Healthcare City [24].
Egypt
Egypt’s Ministry of Health and Population (MOHP)
developed an extensive policy on CB banking using guide-
lines and codes of ethics from the United States and Europe
as a template. In 2007 it approved a National Blood Policy
with procedural guidelines for CB collection and storage to
be overseen by the country’s National Blood Transfusion
Standards [25]. Before a CB bank can operate in Egypt, it must
receive approval from Al-Azhar University, a preeminent
center for Islamic learning in Cairo. Egypt permits both pri-
vate and public banking in the country, as long as certain
regulations are fulﬁlled to minimize the potential of com-
mercial exploitation.
Egypt’s HSC transplant program, established in 1989, has
been slow to develop and now performs more transplants
using peripheral blood than bone marrow [26]. Growing
political mistrust among Egyptians since 2013 has resulted in
a decrease in blood donations in general, so CB donation
rates may also be suffering [27]. However, research on CB
transplants is taking place at several universities and
research centers in the country, including a clinical trial on
autologous CB transplants in neonates at Ain Shams Uni-
versity in Cairo [28].
In 2011 the MOHP created the National Stem Cell Com-
mittee tasked with establishing regulations for stem cell
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MOHP also inaugurated a new stem cell research center at
Sheikh Zayed Hospital in 2012, and Zewail City of Science and
Technology opened a Center for Stem Cell Research and
Regenerative Medicine in 2013 [29]. Zewail City is also
partnering with Assiut University to build a public CB bank
[30].
The slow development of public CB banking in Egypt is
likely linked to the political and funding instabilities in the
country. Several private banking options are available,
including CellSafe, which acquired a MOHP license in 2008
and has stored over 1000 CB units for an initial $1600 fee and
$140 annually thereafter [31]. Stem-Health S.A., a FACT-
accredited family CB bank, also has a license to establish a
private bank in Egypt, but to date no development has star-
ted [32].
Qatar
In 2009 Virgin Health Bank moved its headquarters from
the United Kingdom to Qatar. CB collection was launched
in 2010 at Hamad Medical Corporation’s Women’s Hospital
and has now expanded to several other facilities [33]. No
reported CB transplants have taken place in Qatar yet.
However, the National Center for Cancer Care & Research has
a 5-bed bone marrow transplantation unit specializing in
autologous HSC transplants following Hamad Medical Cor-
poration guidelines [34].
Virgin Health Bank, the only CB bank in Qatar to receive a
license from the Supreme Council of Health, is located in
Qatar Science and Technology Park. It ﬁrst launched a private
storage option and later added hybrid “community banking”
that stores 5 mL of the CB unit privately and the rest of the
unit publicly “for use in the wider patient community” [35].
This service depends on the future development of cell
expansion procedures because 5 mL is not adequate for
transplant.
Qatar’s Supreme Council of Health developed a stem cell
research policy in 2010, whichwas approved by the country’s
National Research Ethics Committee in 2011. These guide-
lines allow for research involving stem cells from CB as well
as human embryos. In 2012, following the Qatar Interna-
tional Conference on Stem Cell Science and Policy, the
guidelines were enacted into legislation and are an impor-
tant step to increasing Qatar’s capacity for CB research and
transplants [36].
ARAB WORLDeRELATED ISSUES FOR CB BANKING
Several issues concerning CB banking relate uniquely to
the Arab world. With religious permissibility, considerable
biological risk factors, and sizeable economic considerations,
the region would beneﬁt from greater availability of public
CB units. Therefore, public CB banking programsdespecially
those with family-directed donation optionsdare over-
whelmingly favored over private CB banking in Arab
countries.
Public Accessibility and Acceptance
Although the umbilical cord itself is not given signiﬁcance
in Islam, parts of the body, including blood, are often given
special consideration. Many Muslims consider medical
and scientiﬁc research to be fard kifaya (“a collective religious
duty”) as supporting the principle of maslaha (“promoting
public good”). In general, the judgments on permissible
versus impermissible actions in Islamic law are derived
from the Qur’an and the hadith (actions and sayings ofProphet Mohammed). If these sources do not speciﬁcally
reference the issue, such as using CB, and if no precedent is
available, Islamic jurisprudential scholars follow a speciﬁc
methodology of analysis to issue a fatwa [12]. In addition to
the Muslim World League’s fatwa in 2003, which permits
using CB for research and therapy with parental consent,
Islam encourages public donation over private storage. With
Muslim-majority populations in these countries, the cultural
viewpoints support voluntary CB donation and its use in
medical treatments and research.
Public awareness is a major component of CB donation
success. Non-white populations have difﬁculty ﬁnding
registered HSC donorsdwhether from bone marrow, pe-
ripheral blood, or CB. Of the 20million HSC donors registered
globally, fewer than 50 are registered in the Arabian Gulf
countries [37]. Over 60 registries exist worldwide, but the
only 1 available in the Arab world opened in 2011 at
KAIMRC’s CB bank. The probability of a Jordanian ﬁnding a
matching unrelated stem cell donor on an international
registry has been estimated to be only 2% to 5%, which is
signiﬁcantly lower than the 50% to 60% likelihood for pa-
tients of white descent [38]. Even if an allogeneic donor were
found, the logistics of timing the donation and transplant
overseas would be difﬁcult. Public CB banks can help to ﬁll
this gap by providing an alternate source of HSCs for the
diverse and growing Arab population.
In addition to traditional donation procedures, family-
directed donation programs require further infrastructure
for prescreening and advising. Health care providers, espe-
cially obstetricians, should provide information early in
pregnancy about the options for CB banking and encourage
public donation over private storage for the general popu-
lation. Surveys in other countries have indicated strong
public support for CB donations, but many parents do not
participate because of a lack of awareness [39,40]. Involving
health care providers in CB banking programs is important
for decreasing this educational gap and increasing CB
donations.
Region-Speciﬁc Biological Factors
Three major issues relevant to the Arab worldd
consanguinity, hemoglobinopathies, and bloodborne
diseasedjustify the need to support public CB banking in the
region. Important disease indications for transplant include
acute leukemia, bone marrow failure syndromes, and he-
moglobinopathies, the latter 2 of which appeared at higher
rates in the region than found in Europe. Therefore, CB
banking programs that offer both public and family-directed
donation programs are especially relevant.
Consanguineous marriages are deﬁned clinically as a
union between 2 individuals biologically related as second
cousins or closer. High rates of consanguinity have been
associated with several diseases treatable with CB trans-
plants, including leukemia, lymphoma, and beta-
thalassemia. The rate of consanguinity ranges between 28%
and 63% in Jordan, over 50% in the current Qatari and Saudi
generations, and up to 60% to 80% in rural Egypt [41,42].
Although large family size and intermarriage may
decrease the need for unrelated CB transplants, these de-
mographic factors are declining. In the future, it may be
increasingly difﬁcult to ﬁnd related donors as families
become smaller [43]. In fact, the number of allogeneic HSC
transplants performed in the region steadily increased from
the mid-1980s to the mid-2000s, totaling 1078 in Egypt, 251
in Jordan, and 2057 in Saudi Arabia (no data from Qatar or
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of Saudis do not have a related donor source, and the likeli-
hood of ﬁnding an unrelated donor on Western registries is
low [18]. Therefore, alternative donor sources remain
essential [42].
Carrier frequencies of hemoglobinopathies are also high
in the region, with thalassemias and sickle-cell anemia
among the most common single gene disorders in the Arab
world [44]. For example, carrier frequency for beta-
thalassemia in Egypt is estimated to be 6% to 10%, making
HSC transplants an important medical intervention for the
population.
Finally, endemic bloodborne diseases in the region pre-
sent a challenge to CB banking. For example, hepatitis B in-
fects 4.3 million people each year in the Arab world [45,46].
Stringent testing of CB is required to preemptively identify
infectious diseases and to ensure CB transplant safety. Both
private and public banks should be subjected to equivalent
testing regulations. Educational campaigns should also
emphasize that necessary steps are taken to ensure safety of
the blood so parents are not afraid to either donate or receive
CB blood.
Economic and Policy Incentives for Regional
Coordination
Public CB banks require signiﬁcant ﬁnancial support to
build a sizable inventory of high-quality, transplantable CB
units. Governments can improve transplant opportunities for
their populations and reduce the associated costs by creating
a national CB registry. Especially for countries with limited
budgets, transplanting CB units collected from the country’s
public banks is more economical than relying on costly in-
ternational sources. Higher matching rates of CB transplants
among Arab populations because of similar genetic back-
grounds and tissue compatibility suggest greater cost-
effectiveness of programs in the region [18,47]. Because
public CB banks primarily generate revenue by charging
transplant centers a fee for procuring CB units, a higher
turnover rate of units makes the banks more ﬁnancially
sustainable. However, simply increasing the number of CB
units in storage may not be the most ﬁnancially sound so-
lution. Several countries, including the United States, United
Kingdom, and Japan, have conducted population-speciﬁc
studies to determine the ideal number of CB units in public
storage to cover a sufﬁcient percentage of the population
while not wasting resources [47-49]. Arab countries should
carry out similar analyses to determine their national in-
ventory needs and ideal ratios to develop their programs in a
cost-effective manner.
National CB banking programs should consider cooper-
ating to create a regional stem cell donor registry. A more
extensive registry of Arab donors will increase
donorepatient matching rates and CB unit turnover and
minimize shipment costs. A regional registry will also
require mandatory and more stringent CB collection and
storage regulations as well as coordination strategies be-
tween banks and transplant centers. However, these steps
will improve long-term outcomes, especially as the need for
HSC transplants continues to increase [50]. Stronger thera-
peutic programs will also help to reduce the economic
burden posed by the high prevalence of hemoglobinopathies
and other diseases treatable with CB transplants [44].
CB collection practices and the availability of trained
medical staff are important for successful transplant out-
comes. Collected CB units that fail to meet transplantstandards are a waste of resources. For example, stafﬁng
shortages at KAIMRC resulted in a collection loss of 40% of
the CB units available for donation, and, even then, most
collected CB units were later rejected for inadequate quality
[51]. Since then, KAIMRC implemented education and
awareness programs and staff recruitment initiatives that
have positively impacted the CB collection and storage suc-
cess rates. Other national CB banking programs should also
prioritize personnel training to address the current shortage
in transplant availability, data collection, and research [49].
CONCLUSION
The demonstrated successes so far of the public CB pro-
grams in the Arab world, most notably in Saudi Arabia and
the UAE, are positive trends for the region. Major in-
vestments to create new public CB banks in Jordan and Egypt,
as well as Jordan’s leadership in policy initiatives, are also
promising developments. These programs require a
commitment to training, education, research, and facilities to
ensure their full integration into the national health care
infrastructure.
The region is in need of robust policies and programs for
HSC transplants, CB banks, and research, especially so it does
not fall behind as these ﬁelds continue to progress interna-
tionally. Governments should engage experts in medicine,
policy, and religion to create guidelines for sustainable and
effective CB banking programs. Several factors in the region,
including population demographics and accessibility of
medical treatments, strongly incentivize widening public CB
storage capabilities with family-directed donation programs.
In addition, the lack of knowledge about public opinion and
level of awareness concerning these topics makes research,
educational initiatives, and medical staff training even more
critical in Arab countries.
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